| Product NDC: | 33342-037 | 
| Proprietary Name: | Escitalopram Oxalate | 
| Non Proprietary Name: | Escitalopram Oxalate | 
| Active Ingredient(s): | 10 mg/21 & nbsp; Escitalopram Oxalate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 33342-037 | 
| Labeler Name: | Macleods Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA202210 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120911 | 
| Package NDC: | 33342-037-12 | 
| Package Description: | 100 TABLET, FILM COATED in 1 CARTON (33342-037-12) | 
| NDC Code | 33342-037-12 | 
| Proprietary Name | Escitalopram Oxalate | 
| Package Description | 100 TABLET, FILM COATED in 1 CARTON (33342-037-12) | 
| Product NDC | 33342-037 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Escitalopram Oxalate | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20120911 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Macleods Pharmaceuticals Limited | 
| Substance Name | ESCITALOPRAM OXALATE | 
| Strength Number | 10 | 
| Strength Unit | mg/21 | 
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |